MARKET

PDEX

PDEX

Pro Dex
NASDAQ

Real-time Quotes | Nasdaq Last Sale

26.03
+0.14
+0.52%
Opening 13:08 09/16 EDT
OPEN
25.91
PREV CLOSE
25.89
HIGH
26.75
LOW
25.85
VOLUME
26.96K
TURNOVER
--
52 WEEK HIGH
42.60
52 WEEK LOW
21.25
MARKET CAP
94.88M
P/E (TTM)
22.98
1D
5D
1M
3M
1Y
5Y
Should You Think About Buying Pro-Dex, Inc. (NASDAQ:PDEX) Now?
Pro-Dex, Inc. ( NASDAQ:PDEX ), is not the largest company out there, but it saw significant share price movement during...
Simply Wall St. · 6d ago
60 Biggest Movers From Yesterday
Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.
Benzinga · 08/30 09:18
NeuroMetrix, Reneo Pharmaceuticals leads healthcare gainers; Cassava Sciences, Applied Therapeutics among major losers
Gainers: NeuroMetrix (NASDAQ:NURO) +54%, Reneo Pharmaceuticals (NASDAQ:RPHM) +24%, Neoleukin Therapeutics (NASDAQ:NLTX) +21%, Chembio Diagnostics (NASDAQ:CEMI) +17%, InspireMD (NASDAQ:NSPR) +14%. Losers: Cassava Sciences (NASDAQ:SAVA) -28%, Applied Therape...
Seekingalpha · 08/27 15:06
Top Midday Decliners
MT Newswires · 08/27 14:09
Wall Street Set for Cautiously Higher Open Ahead of Powell's Jackson Hole Speech
MT Newswires · 08/27 09:35
BRIEF-Pro-Dex Quarterly Earnings Per Share $0.22
reuters.com · 08/26 20:35
Pro-Dex EPS misses by $0.07, misses on revenue
Pro-Dex (NASDAQ:PDEX): Q4 GAAP EPS of $0.22 misses by $0.07. Revenue of $9.4M (-15.5% Y/Y) misses by $1M. Shares -2.1%. Press Release
Seekingalpha · 08/26 20:30
Pro-Dex Q4 EPS $0.22 Down From $0.64 YoY, Sales $9.40M Down From $11.13M YoY
Pro-Dex (NASDAQ:PDEX) reported quarterly earnings of $0.22 per share. This is a 65.63 percent decrease over earnings of $0.64 per share from the same period last year. The company reported $9.40 million in sales this
Benzinga · 08/26 20:01
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PDEX. Analyze the recent business situations of Pro Dex through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PDEX stock price target is 39.00 with a high estimate of 39.00 and a low estimate of 39.00.
EPS
Institutional Holdings
Institutions: 42
Institutional Holdings: 944.53K
% Owned: 25.91%
Shares Outstanding: 3.65M
TypeInstitutionsShares
Increased
6
9.64K
New
7
39.26K
Decreased
11
47.34K
Sold Out
7
41.82K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.17%
Healthcare Equipment & Supplies
-0.50%
Key Executives
Chairman/Independent Director
Nicholas Swenson
President/Chief Executive Officer/Chief Operating Officer/Director
Richard Van Kirk
Chief Financial Officer
Alisha Charlton
Independent Director
Raymond Cabillot
Independent Director
William Farrell
Independent Director
David Hovda
Independent Director
Katrina Philp
No Data
About PDEX
Pro-Dex, Inc. (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through three segments: Pro-Dex, OMS and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce. The OMS segment is engaged in providing multi-axis motion control applications. In addition to Pro-Dex, the names Micro Motors and Oregon Micro Systems are used for marketing purposes as brand names. The Company provides engineering consulting services, as well as quality and regulatory consulting services, to a range of industries through EDS.

Webull offers kinds of Pro-Dex Inc stock information, including NASDAQ:PDEX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDEX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PDEX stock methods without spending real money on the virtual paper trading platform.